Anti-Docking Protein 2 antibodies are used for the immunodetection of the protein encoded by the DOK2 gene. In humans, the canonical protein has a reported length of 412 amino acid residues and a mass of 45.4 kDa. It is reported to be highly expressed in peripheral blood leukocytes, lymph nodes and spleen. A member of the DOK protein family, it is known to be involved with receptor-mediated signaling pathways and MAPK cascade signaling pathways. Post-translational modifications have been described, including phosphorylation. Other names for this target antigen include p56dok-2, docking protein 2, 56kD, docking protein 2, 56kDa, downstream of tyrosine kinase 2, p56(dok-2), and p56DOK. Gene orthologs have been identified in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of Docking Protein 2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. Immunofluorescence and Immunohistochemistry are also common applications.